EDITORIAL

Minor renal dysfunction: an emerging independent cardiovascular risk factor

E Ritz

Correspondence to:
Correspondence to:
Professor Eberhard Ritz, Bergheimer Strasse, 56a Heidelberg, 69115, Germany;
prof.e.ritz@t-online.de

---

Because of the excessive cardiac risk, treating a patient with renal dysfunction should no longer be regarded as primary, but rather as secondary prevention

---

Keywords: renal dysfunction; risk factors

Abbreviations: ACE, angiotensin converting enzyme; GRACE, global registry of acute coronary events; HOPE, heart outcomes prevention evaluation; HOT, hypertension optimal treatment; NO, nitric oxide

The first 150 words of the full text of this article appear below.

Following the seminal observation of Lindner and colleagues¹ on the excessive cardiovascular mortality in patients with end stage renal disease on renal replacement therapy, this observation has been repeatedly confirmed. It is currently known that in patients on renal replacement therapy the relative risk of dying from cardiac causes is higher by a factor of 10–100, depending on age.²

It has only recently been recognised that even minor renal dysfunction, as reflected by an increase in urinary albumin excretion and/or a decrease in glomerular filtration rate, is an independent cardiovascular risk factor³ which should be added to the known factors contributing to the Framingham risk score.

This has again been confirmed and extended by the present study of Santopinto and colleagues,³ published in this issue of Heart, who report on an impressively large prospective multicentre observational study covering 11 774 patients in 14 countries hospitalised for acute coronary syndromes. . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Reinecke, H., Brand, E., Mesters, R., Schabitz, W.-R., Fisher, M., Pavenstadt, H., Breithardt, G. (2009). Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease. J. Am. Soc. Nephrol. 20: 705-711 [Abstract] [Full Text]  
• Newsome, B. B., Warnock, D. G., McClellan, W. M., Herzog, C. A., Kiefe, C. I., Eggers, P. W., Allison, J. J. (2008). Long-term Risk of Mortality and End-Stage Renal Disease Among the Elderly After Small Increases in Serum Creatinine Level During Hospitalization for Acute Myocardial Infarction. Arch Intern Med 168: 609-616 [Abstract] [Full Text]  
• Donahue, R. P., Stranges, S., Rejman, K., Rafalson, L. B., Dmochowski, J., Trevisan, M. (2007). Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study. Diabetes Care 30: 1724-1729 [Abstract] [Full Text]  
• Sprangers, B., Evenepoel, P., Vanrenterghem, Y. (2006). Late Referral of Patients With Chronic Kidney Disease: No Time to Waste. Mayo Clin Proc. 81: 1487-1494 [Abstract] [Full Text]  
• Ohtake, T., Kobayashi, S., Moriya, H., Negishi, K., Okamoto, K., Maesato, K., Saito, S. (2005). High Prevalence of Occult Coronary Artery Stenosis in Patients with Chronic Kidney Disease at the Initiation of Renal Replacement Therapy: An Angiographic Examination. J. Am. Soc. Nephrol. 16: 1141-1148 [Abstract] [Full Text]  
• Amann, K., Gross, M.-L., Ritz, E. (2004). Pathophysiology Underlying Accelerated Atherogenesis in Renal Disease: Closing in on the Target. J. Am. Soc. Nephrol. 15: 1664-1666 [Full Text]  
• Ritz, E., McClellan, W. M. (2004). Overview: Increased Cardiovascular Risk in Patients with Minor Renal Dysfunction: An Emerging Issue with Far-Reaching Consequences. J. Am. Soc. Nephrol. 15: 513-516 [Abstract] [Full Text]